Hepatoma Research
All Journals
Search Log In
Home Articles Special Topics Volumes Webinars Videos
Hepatoma Research
Search Submit
Home Articles Special Topics Volumes Webinars Videos

Volume

Associations between physical activity and risk of liver cancer: results from a population-based cohort study in Chinese women

Crosstalk between cancer cell plasticity and immune microenvironment in cholangiocarcinoma

Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon

Precise staging of advanced HCC promotes higher quality of personalized treatment management: Chinese experts consensus on precision diagnosis and management of advanced hepatocellular carcinoma (2023)

Interpretation of Chinese expert consensus on the whole-course management of hepatocellular carcinoma (2023 edition)

Racial, ethnic, and socioeconomic differences in hepatocellular carcinoma across the United States

Introduction of the Chinese expert consensus on postoperative adjuvant therapy for hepatocellular carcinoma (2023 Edition)

Advancements in hepatocellular carcinoma diagnosis and treatment: liquid biopsy and surgery as precision treatment

Is the Mediterranean diet a good preventive measure for NASH?

Introduction of Chinese expert consensus on neoadjuvant therapy for primary liver cancer (2023 edition)

Role of temporary portosystemic surgical shunt during liver resection to prevent a post-resection small for size-like syndrome

The role of percutaneous hepatic perfusion (PHP) in the treatment of cholangiocarcinoma

Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma

Introduction to 2023 Chinese expert consensus on the whole-course management of hepatocellular carcinoma

Progression of liver disease and associated risk of hepatocellular carcinoma

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease

Chinese expert consensus on composite ablation system for the treatment of primary liver cancer (2023 edition)

Lymphatic spread from left-sided intrahepatic cholangiocarcinoma: reconsiderations based on the lymphatic drainage from the liver

Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma

Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways

Emerging data on immune checkpoint inhibitors in the neoadjuvant and adjuvant setting for patients with hepatocellular carcinoma

MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma

Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian treatment guidelines

RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives

Pneumonia promotes pulmonary metastasis of HCC after transplantation via VEGF regulated PI3K/AKT/Cas-9 signaling and angiogenesis

Contemporary perspectives on laparoscopic liver resection for hepatocellular carcinoma: unravelling the potential and limitations

Measures for response assessment in HCC treatment

Hepatic arterial infusion chemotherapy: a review with technical notes

Achieving SVR in patients with hepatitis C-related HCC is associated with an improvement in overall survival: real word data

Interpretation of the updates of the Chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition)

Multidisciplinary assessment of tumor response after internal and external radiation therapy for hepatocellular carcinoma

Glioma-associated oncogene (GLI)-specific decoy oligodeoxynucleotide induces apoptosis and attenuates proliferation, colony formation, and migration in liver cancer cells

The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of treatment sequence

Minimally invasive surgery approaches in major liver resection for hepatocellular carcinoma

Oncologic outcomes and rates of hepatotoxicity following stereotactic body radiotherapy for hepatocellular carcinoma

Liver injury and recovery following radiation therapy for hepatocellular carcinoma: insights from functional liver imaging

Chemoprevention of hepatocellular carcinoma associated with metabolic dysfunction-associated steatotic liver disease: an updated review

Impact of occult hepatitis B virus infection and high-fat diet on hepatocellular carcinoma development

Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments

Evaluation of the outcomes of staging laparoscopy in intrahepatic cholangiocarcinoma patients undergoing surgical resection: a multicenter retrospective study in China

MASLD: an emerging factor in the pathophysiology and clinical management of ICC

Transarterial intervention therapy combined with systemic therapy for HCC: a review of recent five-year articles

The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review

Hepatocellular carcinoma recurrence after liver transplantation: risk factors, targeted surveillance and management options

Advances in radiomics applications for intrahepatic cholangiocarcinoma: a comprehensive review and future directions

Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer

Radiotherapy efficacy and prognostic factors in hepatocellular carcinoma patients with cardiophrenic angle or superior diaphragmatic lymph nodes metastasis

Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review article

Radioembolization for hepatocellular carcinoma: updated strategies and evolving clinical applications

Local and systemic thrombotic complications in cirrhotic patients with hepatocellular carcinoma

Activator protein-1 in liver pathology: from precancerous diseases to hepatocellular carcinoma

Advances in external beam radiation for hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) and particle therapy

Sex differences in hepatocellular carcinoma

Prognostic value of lymphocyte subset levels in hepatocellular carcinoma following conventionally fractionated <i>vs</i>. stereotactic body radiotherapy

Detection of urine circulating tumor DNA using droplet digital PCR for predicting hepatocellular carcinoma recurrence

Actions for 0 selected articles

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2026 OAE Publishing Inc., except certain content provided by third parties